Timothy J Littlewood
Overview
Explore the profile of Timothy J Littlewood including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eyre T, Van-Hamel-Parsons V, Wang L, Hughes K, Littlewood T
Case Rep Hematol
. 2012 Sep;
2011:939080.
PMID: 22937315
We report the case of a patient with severe systemic symptoms (weight loss, malaise, and anorexia), eosinophilic oesophagitis, and raised inflammatory markers coinciding with the use of lisinopril. The onset...
2.
3.
Littlewood T, Kallich J, San Miguel J, Hendricks L, Hedenus M
J Pain Symptom Manage
. 2006 Apr;
31(4):317-25.
PMID: 16632079
Anemia-related fatigue in cancer patients reduces health-related quality of life (HRQOL). These analyses evaluate the effect of hemoglobin level on fatigue and examine the relationship between improved fatigue and HRQOL....
4.
Stasi R, Amadori S, Littlewood T, Terzoli E, Newland A, Provan D
Oncologist
. 2005 Aug;
10(7):539-54.
PMID: 16079321
The management of cancer-related anemia with erythropoietic agents presents many unresolved issues. We reviewed the literature relating to epoetin alfa (Eprex)/Epypo); Ortho Biotech/Janssen-Cilag, High Wycombe, United Kingdom, http://www.orthobiotech.co.uk; Procrit); Ortho...
5.
Littlewood T, Schenkel B, Liss M
Oncologist
. 2005 Apr;
10(5):357-60.
PMID: 15851794
Comparison of the efficacies of erythropoiesis-stimulating agents (ESAs) between different clinical trials is becoming increasingly common, although differences in study design and populations evaluated can have a considerable effect on...
6.
Fidler C, Watkins F, Bowen D, Littlewood T, Wainscoat J, Boultwood J
Haematologica
. 2004 Jul;
89(7):865-6.
PMID: 15257941
Mutations of the NRAS and TP53 genes and internal tandem duplication (ITD) of the FLT3 gene are among the most frequently observed molecular abnormalities in the myelodysplastic syndromes (MDS) and...
7.
Littlewood T, Nortier J, Rapoport B, Pawlicki M, de Wasch G, Vercammen E, et al.
Hematol Oncol
. 2004 Jan;
21(4):169-80.
PMID: 14735555
Anemia, a commonly occurring morbidity in patients with cancer, often leads to diminished quality of life (QOL). Numerous clinical trials have shown that epoetin alfa treatment improves hematologic and QOL...
8.
Peniket A, Littlewood T, Winearls C
Nephrol Dial Transplant
. 2003 Aug;
18(8):1431-4.
PMID: 12897075
No abstract available.
9.
Hedenus M, Adriansson M, San Miguel J, Kramer M, Schipperus M, Juvonen E, et al.
Br J Haematol
. 2003 Jul;
122(3):394-403.
PMID: 12877666
This phase 3, randomized, double-blind, placebo-controlled study was designed to evaluate the efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies. Patients (n = 344) with lymphoma...
10.